Leading European experts in magnetic resonance for animalsJanuary 11, 2007The UAB SeRMN is enlarging its facilities to make room for two new cutting-edge machines for nuclear magnetic resonance (NMR). The devices are a Bruker BIOSPEC 70/30 spectrometer with a horizontal magnet, making it possible to carry out magnetic resonance spectroscopy imaging in vivo on animals (from mice to rabbits), and an NMR Bruker AvanceII 600 spectrometer combined with a high-resolution liquid chromatography team and a mass spectrometer. Both pieces of equipment will have various applications, especially in the field of biomedical research. In total, the UAB has invested €3 million in the equipment purchased and the work carried out to make room for it. The BIOSPEC 70/30 spectrometer and the AvanceII 600 LC-NMR/MS cost approximately €1.5 million and €900,000 respectively, and were funded between the European Regional Development Fund (ERDF, project UNAB05-33-008), the Spanish Ministry of Education and Science (PCT-020400-2005-19 and PCT-010000-2006-14), the Catalan Government and the University itself. The facilities needed to be enlarged to accommodate the new equipment, and this was funded entirely by the UAB. The work is expected to be completed by May 2007, with the equipment being installed in June. The BIOSPEC 70/30 is very similar to magnetic resonance equipment used for clinical purposes, and makes it possible to carry out magnetic resonance imaging and spectroscopy on small animals. This will be the first equipment of its kind in Catalonia and the third in Spain. The equipment at the UAB will include an ultra-shielded and refrigerated superconducting magnet with a 30cm bore diameter and new-generation electronics with more powerful amplifiers, steeper gradients and double synthesising waves. The BIOSPEC 70/30 will be set up for a wide variety of experiments for the detection of different nuclei, and will make it possible to obtain high-resolution and high-quality images. Because of the equipment's sensitivity, it will be set up inside a Faraday cage to protect it from external electromagnetic interference.
The AvanceII 600 LC-NMR/MS is aimed more towards basic research. It will be the first equipment in Spain to combine integrally magnetic resonance techniques, liquid chromatography and mass spectrometry. It will include an ultra-shielded and superconducting 14-tesla magnet and new-generation electronics. The liquid chromatograph to which it will be joined will separate the samples into different fractions, and these will then be analysed using a mass spectrometer and the NMR spectrometer. This easy-to-upgrade equipment has many applications and will be very useful for biomedical research. The BIOSPEC 70/30 will, for example, enable researchers to advance their research into cancer, neurological diseases, diabetes, and other metabolic conditions and disorders through MR studies on animal models. Obviously it will also be possible to study plants used in agrigenomics. Furthermore, the AvanceII 600 LC-NMR/MS spectrometer will make it possible to work with libraries of compounds for pharmacological applications and to analyse liquid samples in the field of proteomics and metabonomics (analysing changes in the metabolism of animals to diagnose diseases earlier and more accurately), as well as food samples. Universitat Autonoma de Barcelona | |||||||||||||||||||||
|
Related Magnetic Resonance Current Events and Magnetic Resonance News Articles Risk and reward compete in brain That familiar pull between the promise of victory and the dread of defeat - whether in money, love or sport - is rooted in the brain's architecture, according to a new imaging study. Scientists adapt economics theory to trace brain's information flow Scientists have used a technique originally developed for economic study to become the first to overcome a significant challenge in brain research: determining the flow of information from one part of the brain to another. Atomic-resolution views suggest function of enzyme that regulates light-detecting signals in eye An atomic-resolution view of an enzyme found only in the eye has given researchers at the University of Washington (UW) clues about how this enzyme, essential to vision, is activated. Novel Imaging Approach May Assist in Predicting Success of Treatment For Atrial Fibrillation University of Utah researchers have developed a magnetic resonance imaging (MRI)-based method for detecting and quantifying injury to the wall of the heart's left atrium in patients who have undergone a procedure to treat atrial fibrillation. Zooming way in, technique offers close-ups of electrons, nuclei Providing a glimpse into the infinitesimal, physicists have found a novel way of spying on some of the universe's tiniest building blocks. MU scientists 'see' how HIV matures into an infection After improving the sensitivity of nuclear magnetic resonance (NMR), researchers at the University of Missouri actually watched the HIV-1 protease mature from an inactive form into an active infection. This process has never been directly visualized before. The findings appear today in the journal Nature. Groundbreaking Discovery May Lead to Stronger Antibiotics The last decade has seen a dramatic decline in the effectiveness of antibiotics, resulting in a mounting public health crisis across the world. A new breakthrough by University of Virginia researchers provides physicians and patients a potential new approach toward the creation of less resistant and more effective antibiotics. Direct recording shows brain signal persists even in dreamless sleep Neuroscientists at Washington University School of Medicine in St. Louis have taken one of the first direct looks at one of the human brain's most fundamental "foundations": a brain signal that never switches off and may support many cognitive functions. MRI spots DCIS in mice A new magnetic resonance imaging procedure can detect very early breast cancer in mice, including ductal carcinoma in situ (DCIS), a precursor to invasive cancer. Some of the tumors detected were less than 300 microns in diameter, the smallest cancers ever detected by MRI. Groundbreaking findings on autism to be presented at Carnegie Mellon international symposium Today's autism research draws on a variety of scientific disciplines, from genetics to functional magnetic resonance imaging (fMRI) to neural development. At the 35th Carnegie Symposium on Cognition, "Development and Brain Systems in Autism," 16 of the world's most prominent autism researchers will present their latest groundbreaking findings on the disorder and discuss the direction of future study that will continue to improve scientists' understanding of autism. More Magnetic Resonance Current Events and Magnetic Resonance News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||